Overview
- Third-quarter adjusted EPS of $1.60 on revenue of $102.87 billion topped LSEG estimates of $1.37 and $98.85 billion.
- CVS raised its 2025 adjusted EPS guidance to a range of $6.55 to $6.65 per share.
- A $5.73 billion non-cash impairment tied to health-care delivery assets led to a quarterly net loss of $3.99 billion.
- Aetna’s medical loss ratio improved to 92.8%, helped by favorable premium deficiency reserve effects and stronger government business performance.
- Pharmacy and consumer wellness sales rose 11.7% to $36.21 billion, boosted by prescriptions acquired from Rite Aid, as CVS closes 16 Oak Street clinics with an $83 million charge and plans fewer new sites in 2026.